Management of patients with gastroesophageal reflux disease: A long- term, follow-up study

Current Therapeutic Research - Clinical and Experimental

Volumn 59, Issue 5, 1998, Pages 275-287

  Gambitta, Pietro ^a   Indriolo, Amedeo ^a   Colombo, Paola ^a   Grosso, Claudio ^a   Pirone, Zenia ^a   Rossi, Alfredo ^a   Bini, Marta ^a   Zanasi, Giulio ^a   Arcidiacono, Raffaele ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Gastroesophageal reflux; Longterm management; Prognostic factors

Indexed keywords

CISAPRIDE; OMEPRAZOLE; RANITIDINE;

ADULT; ARTICLE; BARIUM MEAL; CLINICAL ARTICLE; DIET THERAPY; ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; LIFESTYLE; MALE; PH MEASUREMENT; PRIORITY JOURNAL; PROGNOSIS; STOMACH FUNDOPLICATION; TREATMENT PLANNING;

EID: 0031780378     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(98)85068-6     Document Type: Article

References (45)

1. Vantrappen G, Janssens J. Pathophysiology and treatment of gastro-esophageal reflux disease. Scand J Gastroenterol. 1989;24(Suppl 165):7-12.
2. Johnston BT, McFarland RJ, Collins JSA, Love AEG. Symptom index as a marker of gastro-esophageal reflux disease. Br J Surg. 1992;79:1054-1055.
3. Trimble KC, Douglas S, Pryde A, Heading RC. Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux. Dig Dis Sci. 1995;40:1098-1104.
4. Schindlbeck NE, Heinrich C, Konig A, et al. Optimal thresholds, sensitivity and specificity of long term pH-metry for the detection of gastro-esophageal reflux disease. Gastroenterology. 1987;93:85-90.
5. Morton LS, Fromkes JJ. Gastro-esophageal reflux disease: Diagnosis and medical therapy. Geriatrics. 1993;48:60-66.
6. DeCaestecker JS, Blackwell JN, Pryde A, Heading RC. Daytime gastro-esophageal reflux is important in esophagitis. Gut. 1987;28:519-526.
7. Maton PN. Omeprazole. NEJM. 1991;324:965-975.
8. Hetzel DJ. Controlled clinical trials of omeprazole in the long-term management of reflux disease. Digestion. 1992;51(Suppl 1):35-42.
9. Solvell L. Clinical safety of omeprazole. Scand J Gastroenterol. 1989;3(Suppl A):91-97.
10. Ceccatelli P, Janssens J, Vantrappen G, Cucchiara S. Cisapride restores the decreased lower esophageal sphincter pressure in reflux patients. Gut. 1988;29:631-635.
11. Corazziari E, Bontempo I, Anzini F. Effects of cisapride on distal esophageal motility in humans. Dig Dis Sci. 1989;34:1600-1605.
12. Maddern GJ, Jamieson GG, Myers JC, Collins PJ. Effect of cisapride on delayed gastric emptying in gastro-esophageal reflux disease. Gut. 1991;32:470-474.
13. Saye Z, Forget PP. Effect of cisapride on esophageal pH monitoring in children with reflux associated bronchopulmonary disease. J Pediatr Gastroenterol Nutr. 1989;8:327-333.
14. Tytgat GNJ, Anker Hansen OJ, Carling L, et al. Effect of cisapride on relapse of reflux esophagitis, healed with antisecretory drug. Scand J Gastroenterol. 1992;27:175-183.
15. Cucchiara S, Staiano A, Capozzi C, et al. Cisapride for gastro-esophageal reflux and peptic esophagitis. Arch Dis Child. 1987;62:454-457.
16. Baldi F, Bianchi Porro G, Dobrilla G, et al. Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial. J Clin Gastroenterol. 1988;10:614-618.
17. Kuster E, Ros E, Toledo-Pimentel V, et al. Predictive factors of the long term outcome in gastro-esophageal reflux disease: Six year follow up of 107 patients. Gut. 1994;35:8-14.
18. Koelz HR. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs: An analysis of randomized clinical trials. Scand J Gastroenterol. 1989;24(Suppl 156):25-36.
19. Koelz HR, Birchler R, Bretholz A, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology. 1986;91:1198-1205.
20. Hetzel DJ, Dent J, Reed WD. Healing and relapse of severe peptide esophagitis after treatment with omeprazole. Gastroenterology. 1988;95:903-912.
21. Sandmark S, Carlsson R, Fausa O. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind randomized Scandinavian multicenter study. Scand J Gastroenterol. 1988;23:625-632.
22. Johansson J, Johnsson F, Joelsson B, et al. Outcome 5 years after 360 fundoplication for gastro-esophageal reflux disease. Br J Surg. 1993;80:46-49.
23. Johansson KE, Tibbling L. Gastric secretion and reflux pattern in reflux esophagitis before and during ranitidine treatment. Scand J Gastroenterol. 1986;21:487-492.
24. Hasse GM, Ross MN, Gance-Cleveland B, Kolack KE. Extended four-channel esophageal pH monitoring: The importance of acid reflux patterns at the middle and proximal levels. J Pediatr Surg. 1988;23:32-37.
25. Lehman G, Rogers D, Cravens E, Flueckiger J. Prolonged pH probe testing less than 5 cm above the lower esophageal sphincter (LES): Establishing normal control values. Gastroenterology. 1990;98:A77. Abstract.
26. Zaninotto G, DeMeester TR, Schwizer W, et al. The lower esophageal sphincter in health and disease. Am J Surg. 1988;155:104-111.
27. DeMeester TR, Wang CI, Skinner DB, et al. Technique, indications, and clinical use of 24-hour esophageal pH monitoring. J Thorac Cardiovasc Surg. 1980;79:656-670.
28. Savary M, Miller G. The Oesophagus. Solothurn, Switzerland: Gassman; 1977.
29. Mattox HE, Richter JE. Prolonged ambulatory esophageal pH monitoring in the evaluation of gastro-esophageal reflux disease. Am J Med. 1990;89:345-356.
30. Johnsson F, Joelsson B, Gudmundsson K, Greiff L. Symptoms and endoscopical findings in the diagnosis of gastro-esophageal reflux disease. Scand J Gastroenterol. 1987;22:714-718.
31. Johnson LF, DeMeester TR, Haggit RC. Endoscopic signs for gastro-esophageal reflux objectively evaluated. Gastrointest Endosc. 1976;22:151-155.
32. Sladen GE, Riddell RH, Willoughby JMT. Esophagoscopy, biopsy, and acid perfusion test in the diagnosis of reflux esophagitis. BMJ. 1975;i:71-76.
33. Dixon WJ. BMPD Statistical Software. Berkeley. University of California Press; 1983.
34. Isolauri J, Luostarinen M, Isolauri E, et al. Natural course of gastro-esophageal reflux disease: 17-22 year follow up of 60 patients. Am J Gastroenterol. 1997;92:37-41.
35. Schindlbeck NE, Klauser AG, Berghammer G, et al. Three year follow up of patients with gastro-esophageal reflux disease. Gut. 1992;33:1016-1019.
36. Cohen S, Harris LD. Does hiatus hernia affect competence of the gastro-esophageal sphincter? NEJM. 1971;284:1053-1056.
37. Dent J, Dodds WJ, Friedman RH, et al. Mechanism of gastro-esophageal reflux in recumbent asymptomatic human subjects. J Clin Invest. 1980;65:256-267.
38. Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. NEJM. 1982;307:1547-1552.
39. Berstad A, Weberg R, Fryshov Larsen I, et al. Relationship of hiatus hernia to reflux esophagitis. A prospective study of coincidence, using endoscopy. Scand J Gastroenterol. 1986;21:55-58.
40. Kaul B, Petersen E, Myrvold HE, et al. Hiatus hernia in gastroesophageal reflux disease. Scand J Gastroenterol. 1986;21:31-34.
41. Ott DJ, Gelfand DW, Chen YM, et al. Predictive relationship of hiatal hernia to reflux esophagitis. Gastrointest Radiol. 1985;10:317-320.
42. Sontag SJ, Schnell TG, Miller TQ, et al. The importance of hiatal hernia in reflux esoph-agitis compared with lower esophageal sphincter pressure or smoking. J Clin Gastroenterol. 1991;13:628-643.
43. Wright RA, Hurwitz AL. Relationship of hiatal hernia to endoscopically proved reflux esophagitis. Dig Dis Sci. 1979;24:311-313.
44. Sloan S, Rademaker AW, Kahrilas PJ. Determinants of gastro-esophageal junction incompetence: Hiatal hernia, lower esophageal sphincter, or both? Ann Intern Med. 1992; 117:977-982.
45. Lundell L. Acid suppression in the long-term treatment of peptic stricture and Barrett's esophagus. Digestion. 1992;51(Suppl 1):49-58.